Patients who will be-, are-, or have been treated with potential cardiotoxic oncological treatment and therefore a referred to specialized cardio-oncology units.
Conditions
Interventions
No intervention will take place. Patients are treated according to routine clinical practice.
Sponsors
University Medical Center Utrecht
Eligibility
Inclusion criteria
Inclusion criteria: - Patients who visit a specialized cardio-oncology unit. - Age =18 years. - Willing and able to provide written informed consent for participation
Exclusion criteria
Exclusion criteria: - Conditions that affect a patient’s ability to provide written informed consent, such as psychiatric or mental disorders, language barriers or other factors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular toxicity | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in oncological treatment due to cardiovascular toxicity; Major Adverse Cardiovascular Events; All-cause mortality; | — |
Contacts
Public ContactJanine Kamphuis
UMC Utrecht
Outcome results
None listed